Page 27 - Read Online
P. 27

Housman et al. J Cancer Metastasis Treat 2021;7:69  https://dx.doi.org/10.20517/2394-4722.2021.159  Page 11 of 12

                   International Mesothelioma Interest Group. Recommendations for uniform definitions of surgical techniques for malignant pleural
                   mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the
                   international mesothelioma interest group. J Thorac Oncol 2011;6:1304-12.  DOI  PubMed
               7.       Taioli E, Wolf AS, Camacho-Rivera M, et al. Determinants of survival in malignant pleural mesothelioma: a surveillance,
                   epidemiology, and end results (SEER) study of 14,228 patients. PLoS One 2015;10:e0145039.  DOI  PubMed  PMC
               8.       Taioli E, Wolf AS, Moline JM, Camacho-Rivera M, Flores RM. Frequency of surgery in black patients with malignant pleural
                   mesothelioma. Dis Markers 2015;2015:282145.  DOI  PubMed  PMC
               9.       Flores RM, Riedel E, Donington JS, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant
                   pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol
                   2010;5:1649-54.  DOI  PubMed
               10.      Hasegawa S. Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc
                   Surg 2014;62:516-21.  DOI  PubMed  PMC
               11.      Ricciardi S, Cardillo G, Zirafa CC, et al. Surgery for malignant pleural mesothelioma: an international guidelines review. J Thorac Dis
                   2018;10:S285-92.  DOI  PubMed  PMC
               12.      Bovolato P, Casadio C, Billè A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma? J Thorac Oncol
                   2014;9:390-6.  DOI  PubMed
               13.      Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of
                   malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6, 626.e1-3.  DOI  PubMed
               14.      Raskin  J,  Surmont  V,  Cornelissen  R,  Baas  P,  van  Schil  PEY,  van  Meerbeeck  JP.  A  randomized  phase  II  study  of
                   pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural
                   mesothelioma (EORTC 1205). Transl Lung Cancer Res 2018;7:593-8.  DOI  PubMed  PMC
               15.      Batirel HF, Metintas M, Caglar HB, et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 2008;3:499-504.
                   DOI  PubMed
               16.      Flores RM. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin
                   Thorac Cardiovasc Surg 2009;21:149-53.  DOI  PubMed
               17.      Sarot IA. Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 1949;4:173-223.  DOI  PubMed  PMC
               18.      Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of
                   the pleura. Experience with 29 patients. Thorax 1976;31:15-24.  DOI  PubMed  PMC
               19.      Flores RM, Krug LM, Rosenzweig KE, et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose
                   radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 2006;1:289-95.  PubMed
               20.      Yan TD, Boyer M, Tin MM, et al. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and
                   prognostic factors. J Thorac Cardiovasc Surg 2009;138:619-24.  DOI  PubMed
               21.      Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative
                   long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg
                   1999;117:54-65.  DOI  PubMed
               22.      Weder W, Kestenholz P, Taverna C, et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural
                   mesothelioma. J Clin Oncol 2004;22:3451-7.  DOI  PubMed
               23.      Weder W, Stahel RA, Bernhard J, et al; Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy
                   followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-202.  DOI  PubMed
               24.      Cho BCJ, Donahoe L, Bradbury PA, et al. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from
                   a single-centre, phase 2 trial. Lancet Oncol 2021;22:190-7.  DOI  PubMed
               25.      Martini N, Bains MS, Beattie EJ. Indications for pleurectomy in malignant effusion. Cancer 1975;35:734-8.  DOI  PubMed
               26.      Wanebo HJ, Martini N, Melamed MR, Hilaris B, Beattie EJ. Pleural mesothelioma. Cancer 1976;38:2481-8.  DOI  PubMed
               27.      Marulli G, Breda C, Fontana P, et al. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques
                   associated with different outcomes? Eur J Cardiothorac Surg 2017;52:63-9.  DOI  PubMed
               28.      Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant
                   pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2011;71:75-81.
                   DOI  PubMed
               29.      Lapidot M, Gill RR, Mazzola E, et al. Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging
                   results and novel prognostic implications based on experience in 355 consecutive patients. Ann Surg 2020.  DOI  PubMed
               30.      Nakamura A, Takuwa T, Hashimoto M, et al. Clinical outcomes with recurrence after pleurectomy/decortication for malignant pleural
                   mesothelioma. Ann Thorac Surg 2020;109:1537-43.  DOI  PubMed
               31.      Sharkey AJ, Bilancia R, Tenconi S, Nakas A, Waller DA. Extended pleurectomy decortication for malignant pleural mesothelioma in
                   the elderly: the need for an inclusive yet selective approach. Interact Cardiovasc Thorac Surg 2017;25:696-702.  DOI  PubMed
               32.      Teh E, Fiorentino F, Tan C, Treasure T. A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc
                   Med 2011;104:69-80.  DOI  PubMed  PMC
               33.      Duranti L, Pardolesi A, Bertolaccini L, et al. Extra-pleural pneumonectomy. J Thorac Dis 2019;11:1022-30.  DOI  PubMed  PMC
               34.      Treasure T, Lang-lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with
                   malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.
                   Lancet Oncol 2011;12:763-72.  DOI  PubMed  PMC
               35.      Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and
   22   23   24   25   26   27   28   29   30   31   32